Christina Kovar, Ph.D.

Director, MIDD Consultant

Portrait-of-Christina-Kovar_Pharmetheus

Bio

  • Joined Pharmetheus in 2023, actively working in client projects
  • Expertise includes pharmacometrics, model-informed precision dosing, and physiologically based pharmacokinetic modeling (especially drug-drug and drug-(drug)-gene interactions) in therapeutic areas such as oncology and gastroenterology
  • Licensed Pharmacist (2019) from Johann Wolfgang Goethe-University in Frankfurt am Main, Germany and Ph.D. in Pharmacometrics (2025) from Saarland University in Saarbrücken, Germany
LinkedInGoogle Scholar

Pharmetheus affiliated publications

Population pharmacokinetics and pharmacokinetics-pharmacodynamics analyses of elafibranor to support dose selection in primary biliary cholangitisPhase 1 interim population PK/PD modeling and recommended phase 2 dose exploration for IMM-1-104: A novel concept oral deep cyclic inhibitor of MEKA Physiologically Based Pharmacokinetic Model of Atorvastatin Acid Predicting CYP3A4 and OATP1B Drug–Drug InteractionsDevelopment of a Physiologically-Based Pharmacokinetic Model for Coproporphyrin I (CP-I) Using the Open Systems Pharmacology Software Suite (PK-Sim and MoBi) for assessment of OATP1B-based DDIs